Replies to post #215247 on Innovation Pharmaceuticals Inc (IPIX)

[KMBJN]

Looks good so far, agreed. We seem to be due for K oral update if they started tox 1 year ago. Let's hope it continues to prove to be low toxicity / non-cytotoxic. I wonder where they are with FDA discussions to start Phase I oral in healthy subjects. Perhaps they want a partner to carry the load. Perhaps they want to see further proof that it can work in ovarian cancer. They say they are running things in parallel, but they only have so much money.

Thanks to you, runninggirl, and Chronic for the refresher on oral K.